Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes

British Journal of Pharmacology

Volumn 162, Issue 2, 2011, Pages 365-377

  Leo, C H ^a   Hart, J L ^a   Woodman, O L ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

diabetes; K Ca channels; mesenteric arteries; nitric oxide; oxidative stress; streptozotocin

Indexed keywords

ACETYLCHOLINE; APAMIN; DIMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANYLATE CYCLASE INHIBITOR; IBERIOTOXIN; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LUCIGENIN; NITRIC OXIDE; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIABETES MELLITUS; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL FACTORS; BLOOD GLUCOSE; BODY WEIGHT; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HEMOGLOBIN A, GLYCOSYLATED; INDOMETHACIN; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 78650391731     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01023.x     Document Type: Article

References (42)

1. Ca channels and caveolin-rich domians. Br J Pharmacol 151: 332-340.
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to receptors and channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1-S254.
3. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, et al. (2009). A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol 157: 540-550.
4. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH, (2002). EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374-380.
5. Cai S, Khoo J, Alp NJ, Channon KM, (2005). Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 48: 1933-1940.
6. Chen G, Suzuki H, Weston AH, (1988). Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 95: 1165-1174.
7. + channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular beds. J Pharmacol Exp Ther 282: 1473-1479.
8. De Vriese AS, Verbeuren TJ, Van De Voorde J, Vanhoutte PM, (2000). Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974.
9. Dora KA, Gallagher NT, McNeish A, Garland CJ, (2008). Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signalling in mesenteric resistance arteries. Circ Res 102: 1247-1255.
10. Dudzinski DM, Michel T, (2007). Life history of eNOS: partners and pathways. Cardiovasc Res 75: 247-260.
11. Edwards G, Feletou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH, (1999). Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol 128: 1788-1794.
12. Edwards G, Feletou M, Weston AH, (2010). Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 459: 863-879.
13. Ellis A, Goto K, Chaston DJ, Brackenbury TD, Meaney KR, Falck JR, et al. (2009). Enalapril treatment alters the contribution of epoxyeicosatrienoic acids but not gap junctions to endothelium-dependent hyperpolarizing factor activity in mesenteric arteries of spontaneous hypertensive rats. J Pharmacol Exp Ther 330: 413-422.
14. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A, (1997). Alteration in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 121: 1383-1391.
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601.
16. Furchgott RF, Zawadzki JV, (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
17. Hamamdzic D, Fenning RS, Patel D, Mohler ER III, Orlova KA, Wright AC, et al. (2010). The Akt pathway is hypo-activated by the synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am J Physiol Heart Circ Physiol 299: H699-H706.
18. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: 14-22.
19. - mice. Am J Physiol Heart Circ Physiol 298: H24-H32.
20. Klatt P, Schmidt K, Lehner D, Glatter O, Bachinger HP, Mayer B, (1995). Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J 14: 3687-3695.
21. Leo CH, Joshi A, Woodman OL, (2010). Short term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery. Am J Physiol Heart Circ Physiol 299: H502-H511.
22. McCulloch AJ, Randall MD, (1998). Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxation in the rat isolated mesenteric arterial bed. Br J Pharmacol 123: 1700-1706.
23. McPherson GA, (1992). Assessing vascular reactivity of arteries in the small vessel myograph. Clin Exp Pharmacol Physiol 19: 815-825.
24. Matsumoto T, Kobayashi T, Kamata K, (2003). Alteration in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 285: H283-H291.
25. Matsumoto T, Kobayashi T, Wakabayashi K, Kamata K, (2005). Cilostazol improves endothelium-derived hyperpolarizing factor type relaxation in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 289: H1933-H1940.
26. Miller A, Drummond G, Schmidt H, Sobey GC, (2005). NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 97: 1055-1062.
27. Miller AA, Desilva TM, Judkins CP, Diep H, Drummond G, Sobey GC, (2010). Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia. Stroke 41: 784-789.
28. Moncada S, Gryglewski R, Bunting S, Vane JR, (1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibit platelet aggregation. Nature 263: 663-665.
29. Mulvany MJ, Halpern W, (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
30. Nishikawa Y, Stepp DW, Chilian WM, (2000). Nitric oxide exerts feedback inhibition on EDHF-induced coronary arterior dilation in vivo. Am J Physiol Heart Circ Physiol 279: H459-H465.
31. Palmer RM, Ashton DS, Moncada S, (1988). Vascular endothelium cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
32. Ca) and connexins: possible relationship to vasodilator function? J Anat 209: 689-698.
33. Ca channels enhance agonist-evoked endothelial nitric oxide synthesis and arterior vasodilation. FASEB J 23: 1138-1145.
34. Shi Y, Ku DK, Man RYK, Vanhoutte PM, (2006). Augmented endothelium-derived hyperpolarization factor mediated relaxation attenuates endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type 1 diabetic rats. J Pharmacol Exp Ther 318: 276-281.
35. Sofola OA, Knill A, Hainsworth R, Drinkhill M, (2002). Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 543: 255-260.
36. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M, (2009). Endothelial dysfunction and vascular disease. Acta Physiol 196: 193-222.
37. Ca channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol 160: 836-843.
38. Wigg SJ, Tare M, Tonta MA, Obrien RC, Meredith IT, Parkinton HC, (2001). Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: 232-240.
39. Woodman OL, Missen MA, Boujaoude M, (2004). Daidzein and 17β-estradiol enchance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol 44: 155-163.
40. Xu J, Zou MH, (2009). Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120: 1266-1286.
41. Young EJ, Hill MA, Wiehler WB, Triggle CR, Reid JJ, (2008). Reduced EDHF responses and connexin activity in mesenteric arteries from insulin-resistant obese zucker rats. Diabetologia 51: 872-881.
42. Yuill KH, Yarova P, Kemp-Harper BK, Garland CJ, Dora KA, (2010). A novel role for HNO in local and spreading vasodilatation in rat mesenteric resistance arteries. Antioxid Redox Signal doi:10.1089/ars.2010.3279.